Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: The effects of subtype-selective agonists and the role of G-protein-mediated signaling.
paper
Cited
Public
Unavailable
- Authors
- Mazarati, AndrΓ©y; LundstrΓΆm, Linda; Sollenberg, Ulla; Shin, Don; Langel, Ulo; Sankar, Raman
- Year
- 2006
- Journal
- The Journal of pharmacology and experimental therapeutics
- PMID
- 16699066
- DOI
- 10.1124/jpet.106.104703
The search for antiepileptic drugs that are capable of blocking the progression of epilepsy (epileptogenesis) is an important problem of translational epilepsy research. The neuropeptide galanin effectively suppresses acute seizures. We examined the ability of hippocampal galanin receptor type 1 (GalR1) and type 2 (GalR2) to inhibit kindling epileptogenesis and studied signaling cascades that mediate their effects. Wistar rats received 24-h-long intrahippocampal infusion of a GalR1/2 agonist galanin(1-29), GalR1 agonist M617 [galanin(1-13)-Gln14-bradykinin(2-9)-amide], or GalR2 agonist galanin(2-11). The peptides were administered alone or combined with an inhibitor of Gi protein pertussis toxin (PTX), Gi-protein activated K+ channels (GIRK) inhibitor tertiapin Q (TPQ), G(q/11) protein inhibitor [D-Arg1,D-Trp(5,7,9),Leu11]-substance P (dSP), or an inhibitor of intracellular Ca2+ release dantrolene. Sixteen hours into drug delivery, the animals were subjected to rapid kindling-60 electrical trains administered to ventral hippocampus every 5 min. M617 delayed epileptogenesis, whereas galanin(1-29) and galanin(2-11) completely prevented the occurrence of full kindled seizures. TPQ abolished anticonvulsant effect of M617 but not of galanin(2-11). PTX blocked anticonvulsant effects of M617 and inversed the action of galanin(1-29) and galanin(2-11) to proconvulsant. dSP and dantrolene did not modify seizure suppression through GalR1 and GalR2, but eliminated the proconvulsant effect of PTX + galanin(1-29) and PTX + galanin(2-11) combinations. We conclude that hippocampal GalR1 exert their disease-modifying effect through the Gi-GIRK pathway. GalR2 is antiepileptogenic through the Gi mechanism independent of GIRK. A secondary proconvulsant pathway coupled to GalR2 involves G(q/11) and intracellular Ca2+. The data are important for understanding endogenous mechanisms regulating epileptogenesis and for the development of novel antiepileptogenic drugs.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Galanin Inhibits Histaminergic Neurons via Galanin Receptor 1. | Khouma A et al. | β | 2026 | β |
| G protein-gated inwardly rectifying K<sup>+</sup> (GIRK/K<sub>ir</sub>3) channels: Molecular, cellular, and subcellular diversity. | MartΓn-Belmonte A et al. | β | 2025 | β |
| Direct modulation of G protein-gated inwardly rectifying potassium (GIRK) channels. | Nguyen H et al. | β | 2024 | β |
| Impairments in hippocampal oscillations accompany the loss of LTP induced by GIRK activity blockade | Contreras A et al. | β | 2023 | β |
| Impairments in hippocampal oscillations accompany the loss of LTP induced by GIRK activity blockade. | Contreras A et al. | β | 2023 | β |
| Neuromedin B excites central lateral amygdala neurons and reduces cardiovascular output and fear-potentiated startle. | Boyle CA et al. | β | 2023 | β |
| Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus. | Caramia M et al. | β | 2023 | β |
| Envisioning the role of inwardly rectifying potassium (Kir) channel in epilepsy. | Akyuz E et al. | β | 2022 | β |
| Ionic signalling mechanisms involved in neurokinin-3 receptor-mediated augmentation of fear-potentiated startle response in the basolateral amygdala. | Boyle CA et al. | β | 2022 | β |
| Kir Channel Molecular Physiology, Pharmacology, and Therapeutic Implications. | Cui M et al. | β | 2021 | β |
| Insights into Potential Targets for Therapeutic Intervention in Epilepsy. | Zavala-Tecuapetla C et al. | β | 2020 | β |
| Roles of K<sup>+</sup> and cation channels in ORL-1 receptor-mediated depression of neuronal excitability and epileptic activities in the medial entorhinal cortex. | Li H et al. | β | 2019 | β |
| Dorsal hippocampal galanin modulates anxiety-like behaviours in rats. | Funck VR et al. | β | 2018 | β |
| Effects of galanin receptor 2 and receptor 3 knockout in mouse models of acute seizures. | Drexel M et al. | β | 2018 | β |
| Neuroanatomical Localization of Galanin in Zebrafish Telencephalon and Anticonvulsant Effect of Galanin Overexpression. | Podlasz P et al. | β | 2018 | β |
| A KCNJ6 gene polymorphism modulates theta oscillations during reward processing. | Kamarajan C et al. | β | 2017 | β |
| Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy. | Medel-Matus JS et al. | β | 2017 | β |
| Hippocampal Transcriptomic Profiles: Subfield Vulnerability to Age and Cognitive Impairment. | Ianov L et al. | β | 2017 | β |
| Inhibition of 17-beta-estradiol on neuronal excitability via enhancing GIRK1-mediated inwardly rectifying potassium currents and GIRK1 expression. | Zhang Y et al. | β | 2017 | β |
| Myocardial protection from ischemia/reperfusion injury by exogenous galanin fragment. | Timotin A et al. | β | 2017 | β |
| Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics. | Metcalf CS et al. | β | 2017 | β |
| Regulation of kindling epileptogenesis by hippocampal Toll-like receptors 2. | Medel-Matus JS et al. | β | 2017 | β |
| The novel anticonvulsant neuropeptide and galanin analogue, NAX-5055, does not alter energy and amino acid metabolism in cultured brain cells. | Aldana BI et al. | β | 2017 | β |
| Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice. | Reyes-Alcaraz A et al. | β | 2016 | β |
| Galanin subtype 1 and subtype 2 receptors mediate opposite anxiety-like effects in the rat dorsal raphe nucleus. | Morais JS et al. | β | 2016 | β |
| Potassium Channels and Human Epileptic Phenotypes: An Updated Overview. | Villa C et al. | β | 2016 | β |
| A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts. | Amini E et al. | β | 2015 | β |
| Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction. | Mayfield J et al. | β | 2015 | β |
| G protein-gated inwardly rectifying potassium channel subunits 1 and 2 are down-regulated in rat dorsal root ganglion neurons and spinal cord after peripheral axotomy. | Lyu C et al. | β | 2015 | β |
| Potential mechanisms and clinical applications of mild hypothermia and electroconvulsive therapy on refractory status epilepticus. | Yang X et al. | β | 2015 | β |
| Activation of galanin receptor 2 stimulates large conductance Ca(2+)-dependent K(+) (BK) channels through the IP3 pathway in human embryonic kidney (HEK293) cells. | Pan NC et al. | β | 2014 | β |
| Alcohol modulation of G-protein-gated inwardly rectifying potassium channels: from binding to therapeutics. | Bodhinathan K et al. | β | 2014 | β |
| Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms. | Jequier Gygax M et al. | β | 2014 | β |
| K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy. | D'Adamo MC et al. | β | 2013 | β |
| Pathogenesis of epilepsy: challenges in animal models. | Hui Yin Y et al. | β | 2013 | β |
| Positive allosteric modulators to peptide GPCRs: a promising class of drugs. | Bartfai T et al. | β | 2013 | β |
| Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). | Bialer M et al. | β | 2013 | β |
| Galanin receptors and ligands. | Webling KE et al. | β | 2012 | β |
| Peripheral galanin receptor 2 as a target for the modulation of pain. | Hulse RP et al. | β | 2012 | β |
| Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. | Casillas-Espinosa PM et al. | β | 2012 | β |
| RGS proteins maintain robustness of GPCR-GIRK coupling by selective stimulation of the G protein subunit GΞ±o. | Chuang HH et al. | β | 2012 | β |
| Sudomotor function and sweat gland innervation in galanin knockout mice. | Vilches JJ et al. | β | 2012 | β |
| Conserved toxic responses across divergent phylogenetic lineages: a meta-analysis of the neurotoxic effects of RDX among multiple species using toxicogenomics. | Garcia-Reyero N et al. | β | 2011 | β |
| The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. | Musto AE et al. | β | 2011 | β |
| Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. | LΓΌscher C et al. | β | 2010 | β |
| Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery. | Robertson CR et al. | β | 2010 | β |
| Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling. | Sankar R et al. | β | 2010 | β |
| Galanin and epilepsy. | Lerner JT et al. | β | 2010 | β |
| Galanin, galanin receptors, and drug targets. | Mitsukawa K et al. | β | 2010 | β |
| Galanin receptor 1 deletion exacerbates hippocampal neuronal loss after systemic kainate administration in mice. | Schauwecker PE | β | 2010 | β |
| GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. | Lu X et al. | β | 2010 | β |
| Neuroprotective role for galanin in Alzheimer's disease. | Counts SE et al. | β | 2010 | β |
| Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. | LΓΆscher W et al. | β | 2010 | β |
| Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). | Bialer M et al. | β | 2010 | β |
| Regulation of the galanin system by repeated electroconvulsive seizures in mice. | Christiansen SH et al. | β | 2010 | β |
| A novel GalR2-specific peptide agonist. | Runesson J et al. | β | 2009 | β |
| Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. | White HS et al. | β | 2009 | β |
| Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia. | Brown JS | β | 2009 | β |
| New and investigational antiepileptic drugs. | Striano P et al. | β | 2009 | β |
| Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). | Bialer M et al. | β | 2009 | β |
| Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues. | Zhang L et al. | β | 2009 | β |
| Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study. | Mazarati A et al. | β | 2008 | β |
| Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. | Bulaj G et al. | β | 2008 | β |
| Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? | Counts SE et al. | β | 2008 | β |
| Variation in Galr1 expression determines susceptibility to exocitotoxin-induced cell death in mice. | Kong S et al. | β | 2008 | β |
| Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity. | Kanter-Schlifke I et al. | β | 2007 | β |
| Kindling epileptogenesis in immature rats leads to persistent depressive behavior. | Mazarati A et al. | β | 2007 | β |
| Regulators of adult neurogenesis in the healthy and diseased brain. | Grote HE et al. | β | 2007 | β |